Trulieve Cannabis (TRLV) Gains from Sales and Divestitures (2021 - 2023)

Trulieve Cannabis (TRLV) has reported Gains from Sales and Divestitures for 3 consecutive years, with $2.9 million the latest figure, recorded in Q2 2023.

• In Q2 2023, Gains from Sales and Divestitures rose 9392.95% year-over-year to $2.9 million; the TTM figure through Jun 2023 stood at $2.9 million (up 9392.95% YoY), while the FY2022 annual figure was $2.9 million, down 0.7% from the prior year.
• Gains from Sales and Divestitures came in at $2.9 million for Q2 2023 at Trulieve Cannabis, roughly flat from $2.9 million in the prior quarter.
• The five-year high for Gains from Sales and Divestitures was $2.9 million in Q4 2021, with the low at $24444.0 in Q1 2022.
• Average Gains from Sales and Divestitures over 3 years is $2.2 million, with a median of $2.9 million recorded in 2022.
• Across the five-year window, Gains from Sales and Divestitures dropped 0.7% in 2022 and soared 11763.85% in 2023, its largest moves.
• Year by year, Gains from Sales and Divestitures stood at $2.9 million in 2021, then decreased by 0.7% to $2.9 million in 2022, then changed by 0.0% to $2.9 million in 2023.
• According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered $2.9 million, $2.9 million, and $2.9 million for Q2 2023, Q1 2023, and Q4 2022 respectively.